rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Drug repurposing
  name:
    name part: Cavalla, David
    role:
      role term: editor.
  type of resource: text
  genre: bibliography
  genre: Electronic books.
  origin info:
    place:
      place term: enk
    date issued: 2022
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: remote
    extent: 1 online resource (xviii, 331 pages) : illlustrations (some color).
  abstract: Drug repurposing is the development of existing drugs for new uses: given that 9 in 10 drugs that enter drug development are never marketed and therefore represent wasted effort, it is an attractive as well as inherently more efficient process. Three repurposed drugs can be brought to market for the same cost as one new chemical entity; and they can also be identified more quickly, an important benefit for patients whose diseases are progressing faster than therapeutic innovation. But repurposing also requires a fresh look at configuring pharmaceutical R&D, considering clinical, regulatory and patent issues much earlier than would otherwise be the case; a holistic gedanken experiment almost needs to be undertaken at the very start of any repurposing development. In addition to new ways of thinking, the discovery of repurposing opportunities can take advantage of artificial intelligence techniques to match the perfect new use for an existing drug. And while repurposing of medicines has been in the mind of every doctor since Hypocrates, modern clinical practice will simply have to adapt to new repurposing techniques in an age where the number of known diseases is increasing much faster than the healthcare dollars available.
  note: edited by David Cavalla.
  note: Includes index.
  note: Includes bibliographical references and index.
  subject:
    topic: Drug development
  subject:
    topic: Médicaments
    topic: Développement
  subject:
    topic: Drug development
  classification: RM301.25 .D78 2022
  classification: 615.1/9
  related item:
    title info:
      title: Drug repurposing
    origin info:
      publisher: Cambridge : Royal Society of Chemistry, 2022
    identifier: (OCoLC)1289264326
  related item:
    title info:
      title: RSC drug discovery series ; 82
  identifier: 9781839163401
  identifier: 1839163402
  identifier: 9781839163418
  identifier: 1839163410
  identifier: 9781788019033
  identifier: 1788019032
  identifier: 6190:6032 Royal Society of Chemistry
  identifier: http://proxy.library.tamu.edu/login
  record info:
    record content source: UKRSC
    record creation date: 220301
    record change date: 20230110214447.0
    record identifier: in00004637220
    language of cataloging:
      language term: eng